Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | CYCLOOXYGENASE 2 | authKW | 656571 | 8% | 26% | 918 |
2 | COX 2 | authKW | 582714 | 7% | 25% | 832 |
3 | CYCLOOXYGENASE | authKW | 420519 | 6% | 21% | 731 |
4 | CELECOXIB | authKW | 303667 | 4% | 27% | 402 |
5 | PROSTAGLANDINS | authKW | 224865 | 7% | 10% | 783 |
6 | COX 2 INHIBITORS | authKW | 184188 | 2% | 32% | 206 |
7 | CRTH2 | authKW | 178400 | 1% | 78% | 82 |
8 | MPGES 1 | authKW | 170926 | 1% | 68% | 90 |
9 | PROSTAGLANDIN D 2 | authKW | 167925 | 1% | 39% | 153 |
10 | MOL BEHAV BIOL | address | 163798 | 1% | 48% | 122 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Oncology | 17220 | 22% | 0% | 2453 |
2 | Chemistry, Medicinal | 8512 | 9% | 0% | 992 |
3 | Biochemistry & Molecular Biology | 6183 | 23% | 0% | 2573 |
4 | Pharmacology & Pharmacy | 5418 | 15% | 0% | 1690 |
5 | Cell Biology | 3352 | 11% | 0% | 1208 |
6 | Gastroenterology & Hepatology | 2218 | 5% | 0% | 554 |
7 | Biophysics | 1039 | 5% | 0% | 515 |
8 | Medicine, Research & Experimental | 1000 | 5% | 0% | 536 |
9 | Urology & Nephrology | 711 | 3% | 0% | 347 |
10 | Pathology | 569 | 3% | 0% | 302 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | MOL BEHAV BIOL | 163798 | 1% | 48% | 122 |
2 | MINASE | 44168 | 1% | 26% | 62 |
3 | AB HANCOCK JR MEM CANC | 43467 | 0% | 43% | 36 |
4 | EXPT THER EUT PHARMACOINFORMAT | 41904 | 0% | 79% | 19 |
5 | GEORGE M OBRIEN KIDNEY UROL DIS | 26452 | 0% | 50% | 19 |
6 | EXPT CARCINOGENESIS MUTAGENESIS | 21065 | 0% | 69% | 11 |
7 | ADV MED DEV | 15587 | 0% | 40% | 14 |
8 | HUMAN GENE SCI | 15545 | 0% | 23% | 24 |
9 | GEORGE OBRIEN KIDNEY UROL DIS | 13932 | 0% | 100% | 5 |
10 | GASTROINTESTINAL OTHER CANC GRP | 12655 | 0% | 45% | 10 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | PROSTAGLANDINS & OTHER LIPID MEDIATORS | 53746 | 2% | 10% | 192 |
2 | PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS | 14497 | 1% | 4% | 129 |
3 | ADVANCES IN PROSTAGLANDIN THROMBOXANE AND LEUKOTRIENE RESEARCH | 13848 | 1% | 8% | 63 |
4 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 8934 | 3% | 1% | 295 |
5 | CANCER PREVENTION RESEARCH | 7797 | 1% | 5% | 60 |
6 | AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY | 4689 | 1% | 2% | 108 |
7 | PROSTAGLANDINS | 4357 | 0% | 3% | 47 |
8 | BRITISH JOURNAL OF PHARMACOLOGY | 3759 | 1% | 1% | 161 |
9 | BIOORGANIC & MEDICINAL CHEMISTRY | 3602 | 1% | 1% | 136 |
10 | CANCER RESEARCH | 2799 | 2% | 1% | 211 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CYCLOOXYGENASE 2 | 656571 | 8% | 26% | 918 | Search CYCLOOXYGENASE+2 | Search CYCLOOXYGENASE+2 |
2 | COX 2 | 582714 | 7% | 25% | 832 | Search COX+2 | Search COX+2 |
3 | CYCLOOXYGENASE | 420519 | 6% | 21% | 731 | Search CYCLOOXYGENASE | Search CYCLOOXYGENASE |
4 | CELECOXIB | 303667 | 4% | 27% | 402 | Search CELECOXIB | Search CELECOXIB |
5 | PROSTAGLANDINS | 224865 | 7% | 10% | 783 | Search PROSTAGLANDINS | Search PROSTAGLANDINS |
6 | COX 2 INHIBITORS | 184188 | 2% | 32% | 206 | Search COX+2+INHIBITORS | Search COX+2+INHIBITORS |
7 | CRTH2 | 178400 | 1% | 78% | 82 | Search CRTH2 | Search CRTH2 |
8 | MPGES 1 | 170926 | 1% | 68% | 90 | Search MPGES+1 | Search MPGES+1 |
9 | PROSTAGLANDIN D 2 | 167925 | 1% | 39% | 153 | Search PROSTAGLANDIN+D+2 | Search PROSTAGLANDIN+D+2 |
10 | NSAIDS | 134731 | 4% | 12% | 419 | Search NSAIDS | Search NSAIDS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 2 |